Holiday Gift Guide P16 Monoclonal Antibody Tool [g2FuJsz0]

P16 Monoclonal Antibody: Your Gateway to Advanced Cancer Research

Welcome to the cutting-edge of cancer research with our P16 Monoclonal Antibody. This innovative product is designed to aid in the detection and understanding of cervical cancer, a critical area in women's health. The P16 Monoclonal Antibody is a powerful tool for researchers and healthcare professionals seeking to diagnose and treat this prevalent disease. Our P16 Monoclonal Antibody is derived from mice and offers high specificity for human proteins, making it an ideal choice for various applications. The antibody is highly reactive to human cells, ensuring accurate and reliable results. This monoclonal antibody is specifically tailored for use in Immunohistochemistry (IHC-P), a technique widely employed in pathology for detecting the expression of proteins in tissue samples.

• High specificity for human proteins
• Reactivity to human cells
• Applications: IHC-P for cervical cancer research

Product Features and Specifications

Our P16 Monoclonal Antibody boasts several key features that set it apart from other products in the market. The antibody is localized to both the nucleus and cytoplasm, allowing for a comprehensive view of its expression within cells. Additionally, it is tissue-specific, primarily expressed in cervical cancer, making it an invaluable tool for diagnosing and grading this type of cancer. The antibody is available in a ready-to-use format, simplifying the workflow and ensuring convenience for researchers. It is stored at 2~8°C to maintain stability and effectiveness, with a shelf life of 12 months. These specifications highlight the product's reliability and ease of use.

• Cellular Localization: Nucleus/Cytoplasm
• Tissue Specificity: Cervical cancer
• Storage: 2~8°C, 12 months shelf life

Practical Applications and Benefits

The P16 Monoclonal Antibody is not just a research tool; it is a valuable asset in the fight against cervical cancer. Its ability to detect and grade cervical epithelioma-like lesions, particularly high-grade squamous intraepithelial lesions (HSIL), is crucial for early diagnosis and effective treatment planning. By providing a detailed understanding of p16 expression, this antibody can help improve patient outcomes and advance the field of cervical cancer research. Investing in our P16 Monoclonal Antibody offers numerous benefits, including enhanced diagnostic accuracy, streamlined workflow, and a direct impact on patient care. With its superior quality and comprehensive applications, this monoclonal antibody is an essential component of any research or clinical laboratory.

• Enhanced diagnostic accuracy for cervical cancer
• Streamlined workflow with ready-to-use format
• Direct impact on patient care and research outcomes